NDC 27241-118 – Fenofibrate
Fenofibrate 67 mg/1 · Capsule · Oral
Product NDC27241-118
Product details
- Brand name
- Fenofibrate
- Generic name
- Fenofibrate
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA210705
- Marketed since
- September 10, 2018
- Listing expires
- December 31, 2026
- Pharmacologic class
- Peroxisome Proliferator Receptor alpha Agonist
Active ingredients
- Fenofibrate 67 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 27241-118-04 | 100 CAPSULE in 1 BOTTLE (27241-118-04) | Sep 10, 2018 |
| 27241-118-05 | 500 CAPSULE in 1 BOTTLE (27241-118-05) | Aug 1, 2019 |
Recalls mentioning this NDC
- D-0611-2026 Jul 1, 2026 · Class II
CGMP Deviations - D-0407-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Fenofibrate products
- 50090-6120 Fenofibrate 134 mg/1 · Capsule · A-S Medication Solutions
- 50090-7994 Fenofibrate 200 mg/1 · Capsule · A-S Medication Solutions
- 27241-119 Fenofibrate 134 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 27241-120 Fenofibrate 200 mg/1 · Capsule · Ajanta Pharma USA Inc.
- 62332-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-084 Fenofibrate 67 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-085 Fenofibrate 134 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-086 Fenofibrate 200 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 60687-713 Fenofibrate 200 mg/1 · Capsule · American Health Packaging
- 43975-306 Fenofibrate 200 mg/1 · Capsule · ANI Pharmaceuticals, Inc.